Literature DB >> 16715089

Osteoclasts degrade endosteal components and promote mobilization of hematopoietic progenitor cells.

Orit Kollet1, Ayelet Dar, Shoham Shivtiel, Alexander Kalinkovich, Kfir Lapid, Yejezkel Sztainberg, Melania Tesio, Robert M Samstein, Polina Goichberg, Asaf Spiegel, Ari Elson, Tsvee Lapidot.   

Abstract

Here we investigated the potential role of bone-resorbing osteoclasts in homeostasis and stress-induced mobilization of hematopoietic progenitors. Different stress situations induced activity of osteoclasts (OCLs) along the stem cell-rich endosteum region of bone, secretion of proteolytic enzymes and mobilization of progenitors. Specific stimulation of OCLs with RANKL recruited mainly immature progenitors to the circulation in a CXCR4- and MMP-9-dependent manner; however, RANKL did not induce mobilization in young female PTPepsilon-knockout mice with defective OCL bone adhesion and resorption. Inhibition of OCLs with calcitonin reduced progenitor egress in homeostasis, G-CSF mobilization and stress situations. RANKL-stimulated bone-resorbing OCLs also reduced the stem cell niche components SDF-1, stem cell factor (SCF) and osteopontin along the endosteum, which was associated with progenitor mobilization. Finally, the major bone-resorbing proteinase, cathepsin K, also cleaved SDF-1 and SCF. Our findings indicate involvement of OCLs in selective progenitor recruitment as part of homeostasis and host defense, linking bone remodeling with regulation of hematopoiesis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16715089     DOI: 10.1038/nm1417

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  304 in total

1.  The haematopoietic stem cell niche at a glance.

Authors:  Cristina Lo Celso; David T Scadden
Journal:  J Cell Sci       Date:  2011-11-01       Impact factor: 5.285

2.  Rac signaling in osteoblastic cells is required for normal bone development but is dispensable for hematopoietic development.

Authors:  Steven W Lane; Serena De Vita; Kylie A Alexander; Ruchan Karaman; Michael D Milsom; Adrienne M Dorrance; Amy Purdon; Leeann Louis; Mary L Bouxsein; David A Williams
Journal:  Blood       Date:  2011-11-28       Impact factor: 22.113

Review 3.  Molecular mechanisms underlying adhesion and migration of hematopoietic stem cells.

Authors:  Aysegul Ocal Sahin; Miranda Buitenhuis
Journal:  Cell Adh Migr       Date:  2012 Jan-Feb       Impact factor: 3.405

4.  Regulating traffic in the hematopoietic stem cell niche.

Authors:  Marc H G P Raaijmakers
Journal:  Haematologica       Date:  2010-09       Impact factor: 9.941

Review 5.  Coexistence of quiescent and active adult stem cells in mammals.

Authors:  Linheng Li; Hans Clevers
Journal:  Science       Date:  2010-01-29       Impact factor: 47.728

6.  Functional inhibition of osteoblastic cells in an in vivo mouse model of myeloid leukemia.

Authors:  Benjamin J Frisch; John M Ashton; Lianping Xing; Michael W Becker; Craig T Jordan; Laura M Calvi
Journal:  Blood       Date:  2011-09-28       Impact factor: 22.113

7.  Cell autonomous and nonautonomous mechanisms drive hematopoietic stem/progenitor cell loss in the absence of DNA repair.

Authors:  Joon Seok Cho; Sung Ho Kook; Andria Rasile Robinson; Laura J Niedernhofer; Byeong-Chel Lee
Journal:  Stem Cells       Date:  2013-03       Impact factor: 6.277

Review 8.  Fat-bone interaction within the bone marrow milieu: Impact on hematopoiesis and systemic energy metabolism.

Authors:  C P Hawkes; S Mostoufi-Moab
Journal:  Bone       Date:  2018-03-15       Impact factor: 4.398

Review 9.  Modeling human hematopoietic stem cell biology in the mouse.

Authors:  Stephen M Sykes; David T Scadden
Journal:  Semin Hematol       Date:  2013-06-11       Impact factor: 3.851

10.  Glycosphingolipid synthesis inhibition limits osteoclast activation and myeloma bone disease.

Authors:  Adel Ersek; Ke Xu; Aristotelis Antonopoulos; Terry D Butters; Ana Espirito Santo; Youridies Vattakuzhi; Lynn M Williams; Katerina Goudevenou; Lynett Danks; Andrew Freidin; Emmanouil Spanoudakis; Simon Parry; Maria Papaioannou; Evdoxia Hatjiharissi; Aristeidis Chaidos; Dominic S Alonzi; Gabriele Twigg; Ming Hu; Raymond A Dwek; Stuart M Haslam; Irene Roberts; Anne Dell; Amin Rahemtulla; Nicole J Horwood; Anastasios Karadimitris
Journal:  J Clin Invest       Date:  2015-04-27       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.